HilleVax, Inc. (HLVX)
NASDAQ: HLVX · Real-Time Price · USD
1.940
-0.015 (-0.77%)
Dec 3, 2024, 1:49 PM EST - Market open
HilleVax Market Cap
HilleVax has a market cap or net worth of $93.57 million as of December 3, 2024. Its market cap has decreased by -85.75% in one year.
Market Cap
93.57M
Enterprise Value
-70.04M
1-Year Change
-85.75%
Ranking
Category
Stock Price
$1.94
Market Cap Chart
Since the IPO on April 29, 2022, HilleVax's market cap has decreased from $538.26M to $93.57M, a decrease of -82.62%. That is a compound annual growth rate of -49.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 29, 2024 | 93.09M | -87.53% |
| Dec 29, 2023 | 746.58M | 25.20% |
| Dec 30, 2022 | 596.32M | 10.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inotiv | 95.17M |
| Genenta Science | 95.11M |
| Aligos Therapeutics | 94.68M |
| MDxHealth | 94.58M |
| Adicet Bio | 93.11M |
| Annovis Bio | 92.58M |
| Allakos | 92.02M |
| Genelux | 91.74M |